Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 147.4

(3.08%)

Total Assets Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual total assets in 2023 was 2.78 Billion ILS , up 14.54% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly total assets in 2024 Q2 was 2.82 Billion ILS , up 1.74% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported annual total assets of 2.43 Billion ILS in 2022, up 6.38% from previous year.
Novolog (Pharm-Up 1966) Ltd reported annual total assets of 2.28 Billion ILS in 2021, up 4.66% from previous year.
Novolog (Pharm-Up 1966) Ltd reported quarterly total assets of 2.77 Billion ILS for 2024 Q1, down -0.33% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported quarterly total assets of 2.98 Billion ILS for 2023 Q3, up 4.03% from previous quarter.

Annual Total Assets Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Historical Annual Total Assets of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	2.78 Billion ILS	14.54%
2022	2.43 Billion ILS	6.38%
2021	2.28 Billion ILS	4.66%
2020	2.18 Billion ILS	1.69%
2019	2.15 Billion ILS	24.14%
2018	1.73 Billion ILS	-4.09%
2017	1.8 Billion ILS	18.55%
2016	1.52 Billion ILS	-7.07%
2015	1.63 Billion ILS	24.33%
2014	1.31 Billion ILS	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	2.82 Billion ILS	1.74%
2024 Q1	2.77 Billion ILS	-0.33%
2023 Q3	2.98 Billion ILS	4.03%
2023 Q2	2.86 Billion ILS	12.58%
2023 Q1	2.54 Billion ILS	4.63%
2023 FY	2.78 Billion ILS	14.54%
2023 Q4	2.78 Billion ILS	-6.53%
2022 Q4	2.43 Billion ILS	-14.13%
2022 FY	2.43 Billion ILS	6.38%
2022 Q2	2.59 Billion ILS	8.05%
2022 Q1	2.4 Billion ILS	5.13%
2022 Q3	2.83 Billion ILS	9.07%
2021 Q3	2.58 Billion ILS	4.77%
2021 Q2	2.46 Billion ILS	4.66%
2021 FY	2.28 Billion ILS	4.66%
2021 Q1	2.35 Billion ILS	7.88%
2021 Q4	2.28 Billion ILS	-11.53%
2020 Q1	2.29 Billion ILS	6.71%
2020 Q3	2.5 Billion ILS	3.06%
2020 Q2	2.43 Billion ILS	5.92%
2020 FY	2.18 Billion ILS	1.69%
2020 Q4	2.18 Billion ILS	-12.7%
2019 Q1	2.17 Billion ILS	25.55%
2019 FY	2.15 Billion ILS	24.14%
2019 Q4	2.15 Billion ILS	-13.41%
2019 Q3	2.48 Billion ILS	11.31%
2019 Q2	2.23 Billion ILS	2.59%
2018 Q4	1.73 Billion ILS	-5.73%
2018 FY	1.73 Billion ILS	-4.09%
2018 Q1	1.82 Billion ILS	1.04%
2018 Q2	1.85 Billion ILS	1.81%
2018 Q3	1.83 Billion ILS	-1.1%
2017 Q2	1.58 Billion ILS	1.08%
2017 Q1	1.57 Billion ILS	3.17%
2017 Q3	1.79 Billion ILS	13.22%
2017 Q4	1.8 Billion ILS	0.41%
2017 FY	1.8 Billion ILS	18.55%
2016 Q1	- ILS	-100.0%
2016 FY	1.52 Billion ILS	-7.07%
2016 Q4	1.52 Billion ILS	-8.8%
2016 Q3	1.67 Billion ILS	0.0%
2015 Q4	1.63 Billion ILS	0.0%
2015 FY	1.63 Billion ILS	24.33%
2014 FY	1.31 Billion ILS	0.0%

Peer Total Assets Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Total Assets	Total Assets Difference